'compound, pharmaceutical compositions, use of a compound, and, depression treatment process, attention deficit hyperactivity disorder (adhd), obesity, migraine, pain, sexual dysfunction, parkinson's disease, alzeheimer disease, or addiction to cocaine or nicotine-containing products (especially tobacco) in an animal or human individual. '

摘要

"COMPOUND, PHARMACEUTICAL COMPOSITIONS, USE OF A COMPOUND, AND, DEPRESSION TREATMENT PROCESS, DISEASE OF HYPERACTIVITY BY ATTENTION DISABILITY (ADHD), OBESITY, MIGRAINE, PAIN, SEXUAL DISEASE, DISEASE, SEXUAL DISEASE, SICKNESS COCAINE OR PRODUCTS CONTAINING NICOTIN (ESPECIALLY TOBACCO) IN AN ANIMAL OR HUMAN INDIVIDUAL "(+) - (2S, 3S) -2- (3-chloro-phenyl) -3,5,5-trimethyl-2 is described -morpholinol and its solvates and pharmaceutically acceptable salts, pharmaceutical compositions comprising them; a process for treating depression, attention deficit hyperactivity disorder (ADHD), obesity, migraine, pain, sexual dysfunction, Parkinson's disease, Alzheimer's disease, or addiction to cocaine or nicotine-containing products (especially tobacco) is also described. ) using such compounds, salts, solvates or compositions.